These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3330722)

  • 1. [Cholinergic agents in the treatment of Alzheimer's disease].
    Zemishlany Z; Davidson M; Davis KL
    Harefuah; 1987 Dec; 113(12):401-4. PubMed ID: 3330722
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A; Rüster P; Romero B; Zimmer R
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholinergic drugs in Alzheimer's disease.
    Davis KL; Mohs RC
    N Engl J Med; 1986 Nov; 315(20):1286-7. PubMed ID: 3773941
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effects of cholinergic preparations in Alzheimer's disease].
    Bradley RJ; Edge MT; Freeman AM
    Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820
    [No Abstract]   [Full Text] [Related]  

  • 5. AF102B: rational treatment strategy for Alzheimer's disease: recent advances.
    Fisher A; Brandeis R; Karton I; Pittel Z; Dachir S; Sapir M; Grunfeld Y; Levy A; Heldman E
    Adv Neurol; 1990; 51():257-9. PubMed ID: 2403717
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to rational drug development in Alzheimer's disease.
    Iversen LL; Iversen SD; Freedman SB; Dawson G; Rupniak N; Hargreaves RJ; Showell GA; Street LJ; Baker R
    Drug Des Discov; 1993; 9(3-4):251-9. PubMed ID: 8400006
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracranial drug administration in Alzheimer's disease.
    Harbaugh RE
    Psychopharmacol Bull; 1986; 22(1):106-9. PubMed ID: 3726055
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies for the pharmacological treatment of Alzheimer's disease.
    Brinkman SD; Largen JW
    Tex Med; 1987 Jan; 83(1):26-30. PubMed ID: 3824229
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alzheimer's disease. Biological and pharmacotherapeutic aspects].
    Hinzen DH
    Fortschr Med; 1986 Jun; 104(23-24):469-71. PubMed ID: 3017825
    [No Abstract]   [Full Text] [Related]  

  • 10. [Galantamine: a novel cholinergic agent for Alzheimer's disease].
    Olazarán J; García G
    Neurologia; 2002 Oct; 17(8):429-36. PubMed ID: 12396973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alzheimer's disease: irreparable damage in the brain?].
    Fessler B
    Med Monatsschr Pharm; 1993 Nov; 16(11):334-5. PubMed ID: 8272002
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholinergic treatments for Alzheimer's disease.
    Roberts F; Lazareno S
    Biochem Soc Trans; 1989 Feb; 17(1):76-9. PubMed ID: 2653922
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: a meta-analysis of the literature.
    Jorm AF
    Aust N Z J Psychiatry; 1986 Jun; 20(2):237-40. PubMed ID: 3464268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic approaches to the treatment of Alzheimer's disease.
    Hollander E; Mohs RC; Davis KL
    Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Alzheimer's disease: hopes and reality.
    Gauthier S; Gauthier L; Bouchard R; Quirion R; Sultan S
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):439-41. PubMed ID: 1933695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 17. Approaches to cholinergic therapy in Alzheimer's disease.
    Iversen LL
    Prog Brain Res; 1993; 98():423-6. PubMed ID: 8248531
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholinergic therapies for Alzheimer's disease: progress and prospects.
    Palmer AM
    Curr Opin Investig Drugs; 2003 Jul; 4(7):820-5. PubMed ID: 14619403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Masterman DL
    J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure.
    Mintzer JE; Kershaw P
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):292-7. PubMed ID: 12673604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.